# Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and Frequency

> **NCT01294982** · PHASE2 · COMPLETED · sponsor: **American Oriental Bioengineering, Inc.** · enrollment: 66 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** AOBO-001
- **DRUG:** AOBO-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01294982
- **Lead sponsor:** American Oriental Bioengineering, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2013-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01294982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01294982, "Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and Frequency". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01294982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*